| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
9,860,000 |
| Market
Cap: |
4.34(M) |
| Last
Volume: |
343,990 |
Avg
Vol: |
274,696 |
| 52
Week Range: |
$0.258 - $0.76 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Titan Pharmaceuticals is a pharmaceutical company developing therapeutics utilizing its drug delivery platform, ProNeura™, for the treatment of select chronic diseases. Probuphine is a product based on its ProNeura technology approved in the United States, Canada and the European Union, for the maintenance treatment of opioid use disorder (OUD). Co. is conducting non-clinical studies with a nalmefene implant for the potential treatment of OUD under a grant from the National Institutes of Health. Co. is collaborating with the Walter Reed Army Institute of Research and South West Research Institute in the early non-clinical evaluation of the ProNeura platform in malaria prophylaxis.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
2,283,690 |
| Total Buy Value |
$0 |
$0 |
$0 |
$1,979,170 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
5 |
| Total Shares Sold |
0 |
0 |
3,747,968 |
3,747,968 |
| Total Sell Value |
$0 |
$0 |
$4,610,000 |
$4,610,000 |
| Total People Sold |
0 |
0 |
1 |
1 |
| Total Sell Transactions |
0 |
0 |
2 |
2 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Smith Ley S |
Director |
– • – |
2010-03-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
112,500 |
|
- |
|
| Kapp Joachim Friedrich |
Director |
– • – |
2010-03-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,002,500 |
|
- |
|
| Macfarlane M David |
Director |
– • – |
2010-03-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
122,500 |
|
- |
|
| Rubin Marc |
Executive ChairmanOfficer |
• • – |
2010-03-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
375,000 |
|
- |
|
| Bauer Victor J Phd |
Director |
– • – |
2010-03-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
11,144 |
|
- |
|
| Kapp Joachim Friedrich |
Director |
– • – |
2008-12-11 |
4 |
B |
$0.04 |
$28,000 |
D/D |
800,000 |
1,000,000 |
2.39 |
- |
|
| Bhonsle Sunil |
Executive VP and COO |
• • – |
2008-10-21 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
365,500 |
|
- |
|
| Rubin Marc |
President & Chief Ex Officer |
• • – |
2008-10-21 |
4 |
A |
$0.00 |
$0 |
D/D |
400,000 |
530,000 |
|
- |
|
| Farrell Robert Edward |
Exec Vice President and CFO |
• – – |
2008-10-21 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
320,580 |
|
- |
|
| Kapp Joachim Friedrich |
Director |
– • – |
2008-08-14 |
4 |
B |
$0.48 |
$43,200 |
D/D |
90,000 |
200,000 |
2.39 |
- |
|
| Kapp Joachim Friedrich |
Director |
– • – |
2008-08-13 |
4 |
B |
$0.36 |
$3,600 |
D/D |
10,000 |
110,000 |
2.31 |
- |
|
| Kapp Joachim Friedrich |
Director |
– • – |
2008-07-07 |
4 |
B |
$0.86 |
$34,012 |
D/D |
39,200 |
100,000 |
2.39 |
- |
|
| Kapp Joachim Friedrich |
Director |
– • – |
2008-07-03 |
4 |
B |
$0.70 |
$7,560 |
D/D |
10,800 |
60,800 |
2.39 |
- |
|
| Kapp Joachim Friedrich |
Director |
– • – |
2008-02-11 |
4 |
B |
$1.33 |
$39,900 |
D/D |
30,000 |
50,000 |
2.39 |
- |
|
| Bhonsle Sunil |
Executive VP and COO |
• • – |
2008-02-11 |
4 |
B |
$1.25 |
$25,000 |
I/I |
20,000 |
95,894 |
2.66 |
- |
|
| Rubin Marc |
President & Chief Ex Officer |
• • – |
2008-02-07 |
4 |
B |
$1.30 |
$6,514 |
D/D |
5,000 |
130,000 |
2.81 |
- |
|
| Rubin Marc |
President & Chief Ex Officer |
• • – |
2008-02-06 |
4 |
B |
$1.30 |
$19,700 |
D/D |
15,000 |
125,000 |
2.81 |
- |
|
| Rubin Marc |
President & Chief Ex Officer |
• • – |
2008-02-05 |
4 |
B |
$1.38 |
$13,800 |
D/D |
10,000 |
110,000 |
2.81 |
- |
|
| Farrell Robert Edward |
Exec Vice President and CFO |
• – – |
2008-01-04 |
4 |
B |
$1.61 |
$6,360 |
D/D |
3,950 |
120,580 |
2.74 |
- |
|
| Farrell Robert Edward |
Exec Vice President and CFO |
• – – |
2008-01-03 |
4 |
B |
$1.61 |
$8,131 |
D/D |
5,050 |
116,630 |
2.74 |
- |
|
| Kapp Joachim Friedrich |
Director |
– • – |
2007-11-02 |
4 |
B |
$1.91 |
$38,200 |
D/D |
20,000 |
20,000 |
2.39 |
- |
|
| Rubin Marc |
President &Chief Ex OfficerOff |
• – – |
2007-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
100,000 |
|
- |
|
| Bhonsle Sunil |
Executive VP and COO |
• • – |
2007-05-22 |
4 |
B |
$2.02 |
$30,300 |
I/I |
15,000 |
75,894 |
2.66 |
- |
|
| Bhonsle Sunil |
Executive VP and COO |
• • – |
2007-05-17 |
4 |
B |
$2.00 |
$12,250 |
D/D |
6,100 |
65,500 |
2.81 |
- |
|
| Bucalo Louis R Md |
President and CEO |
• • – |
2007-05-04 |
4 |
B |
$2.24 |
$99,078 |
D/D |
42,000 |
550,000 |
2.81 |
- |
|
131 Records found
|
|
Page 4 of 6 |
|
|
